Neurofeedback Treatment of Depression and Anxiety

  title={Neurofeedback Treatment of Depression and Anxiety},
  author={D. Corydon Hammond},
  journal={Journal of Adult Development},
  • D. Hammond
  • Published 1 August 2005
  • Psychology
  • Journal of Adult Development
A robust body of research documents that there are biological predispositions that often exist for depression, anxiety, and obsessive–compulsive disorder. However, new research has shown that medication is only mildly more effective than placebo in the treatment of these problems. In treating these conditions, neurofeedback (EEG biofeedback) may offer an alternative to invasive treatments such as medication, ECT, and intense levels of transcrancial magnetic stimulation. This paper reviews the… Expand

Figures from this paper

Neurofeedback with anxiety and affective disorders.
  • D. Hammond
  • Medicine, Psychology
  • Child and adolescent psychiatric clinics of North America
  • 2005
Electroencephalographic biofeedback (neurofeedback) seems to hold promise as a methodology for retraining abnormal brain wave patterns and is less invasive than other methods for addressing biologic brain disorders. Expand
Neurofeedback Treatments for Depression Disorders- Review of Current Advances
Depression is one of the most common and debilitating diseases worldwide, especially in industrialized countries. Depression is traditionally managed with psychological, pharmacological, or physicalExpand
What Is Neurofeedback
ABSTRACT EEG biofeedback (neurofeedback) originated in the late 1960s as a method for retraining brainwave patterns through operant conditioning. Since that time a sizable body of research hasExpand
Treating Mood Disorders
Depression continues to be on the increase in the United States and worldwide, according to current statistics, which supports the need to expand potential treatment options beyond psychotropicExpand
Neurofeedback As a Treatment for Major Depressive Disorder – A Pilot Study
This pilot study suggests that neurofeedback aimed at a reduction of frontal asymmetry of alpha-activity may be effective as a treatment for depression, although this was an open label pilot study. Expand
Neurofeedback for the treatment of depression: Current status of theoretical issues and clinical research
Interest in the relationship between neural functions and emotions has focused particularly on comparisons of activation in the left and right dorsolateral frontal cortices. Beginning with theExpand
Neurofeedback for Anxiety Symptoms Among University Students
Anxiety is a common, universal human emotion, but excessive feelings of anxiety can negatively affect one’s life satisfaction and quality of life. Psychotherapy and medication are the most commonExpand
Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports
The results suggest that EEG neurofeedback should be examined on a larger scale as it offers a promising alternative to existing treatment approaches for negative symptoms in schizophrenia. Expand
The Efficacy of Neurofeedback in Patients with Major Depressive Disorder: An Open Labeled Prospective Study
It is suggested neurofeedback has significant effects in patients with major depressive disorder and could improve depressive symptoms significantly, and anxiety symptoms and clinical illness severity decreased significantly after neurofeedbacks. Expand
The efficacy of neurofeedback among patients with major depressive disorder: preliminary study
Introduction: Alpha asymmetry of the left and right frontal hemisphere is a potential biomarker for major depressive disorder (MDD). Neurofeedback (NFB) is a clinical intervention program forExpand


The Clinical Use of An Alpha Asymmetry Protocol in the Neurofeedback Treatment of Depression: Two Case Studies
Abstract In this study we are presenting case studies of two depressed women who were trained with more than 34 sessions each of EEG biofeedback (neurofeedback) using an Alpha Asymmetry protocol, theExpand
Neurofeedback Treatment of Depression with the Roshi
Abstract Introduction. A patient with severe, medication resistant depression was found to have the frontal alpha asymmetry described in Davidson's (1998a) research as demonstrating a predispositionExpand
A Review of EEG Biofeedback Treatment of Anxiety Disorders
  • N. Moore
  • Psychology, Medicine
  • Clinical EEG
  • 2000
Alpha, theta and alpha-theta enhancements are effective treatments of the anxiety disorders, but research is needed to find out how much more effective they are than placebo, and which variables are important for efficacy. Expand
QEEG-Guided Neurofeedback in the Treatment of Obsessive Compulsive Disorder
Introduction. Blinded, placebo-controlled research (e.g., Sterman, 2000) has documented the ability of brainwave biofeedback to recondition brain wave patterns. Neurofeedback has been used success-Expand
Neurofeedback Treatment for Attention-Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate
It is suggested that neurofeedback was efficient in improving some of the behavioral concomitants of ADHD in children whose parents favored a nonpharmacological treatment. Expand
A Comparison of EEG Biofeedback and Psychostimulants in Treating Attention Deficit/Hyperactivity Disorders
The study compared treatment programs with EEG biofeedback or stimulants as their primary components. An EEG group (EEG) was matched with a stimulant group (MED) by age, IQ, gender and diagnosis. TheExpand
Clinical use of an alpha asymmetry neurofeedback protocol in the treatment of mood disorders: Follow-up study one to five years post therapy
Abstract Background: This study reports on three of six patients who have completed an average of 27 neurofeedback sessions using a patented alpha asymmetry protocol for the treatment of depression.Expand
Alpha wave biofeedback training therapy in alcoholics.
Alpha training appeared useful in the treatment of anxiety, but not other problems, and the absence of significant correlations between amount of change on alpha and the anxiety measures suggests that the improvement may be due to a placebo effect. Expand
Pharmacotherapy of Obsessive‐Compulsive Disorder
Clomipramine, a tricyclic antidepressant, appears to be the most promising therapy in OCD, and other serotonergic agents such as fluoxetine have shown promise, but they have been studied only in a limited number of patients. Expand
Basic Concepts and Clinical Findings in the Treatment of Seizure Disorders with EEG Operant Conditioning
Two issues concerning sensorimotor EEG operant conditioning, or biofeedback, as a therapeutic modality for the treatment of seizure disorders are the focus of this review. The first relates to theExpand